Standout Papers

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Fram... 1997 2026 2006 2016 713
  1. Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections (1997)
    John Rex, Michael A. Pfaller et al. Clinical Infectious Diseases

Immediate Impact

13 from Science/Nature 82 standout
Sub-graph 1 of 21

Citing Papers

Critical advances and future opportunities in upcycling commodity polymers
2022 StandoutNature
Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice
2021 StandoutScience
2 intermediate papers

Works of M. Lancaster being referenced

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997 Standout
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine
1995

Author Peers

Author Last Decade Papers Cites
M. Lancaster 181 216 152 1122 717 24 1.5k
Mimi Healy 138 186 143 759 658 19 1.3k
J. Kroeger 161 480 161 1850 1123 29 2.2k
João Nóbrega de Almeida 128 207 241 1289 1123 73 1.8k
C C Knapp 118 184 193 1122 861 49 1.7k
Anne Bolmström 83 333 113 924 572 25 1.3k
Barbara Zimmer 76 415 160 760 930 41 1.9k
Joveria Farooqi 92 194 143 1582 1298 71 1.9k
Bansidhar Tarai 87 188 122 1452 1056 58 1.8k
H. Jean Shadomy 171 330 303 804 1037 40 2.0k
Adrien Székely 134 242 355 1333 1065 30 1.7k

All Works

Loading papers...

Rankless by CCL
2026